48 results on '"Bonora, Enzo"'
Search Results
2. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
3. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes
4. Diabetes as a cause of death across different COVID-19 epidemic waves
5. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory
6. SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people
7. Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients
8. A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory
9. Fifteen-Year Trends of Cardiogenic Shock and Mortality in Patients with Diabetes and Acute Coronary Syndromes
10. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis
11. A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes
12. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study
13. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
14. Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes
15. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study
16. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
17. Mechanisms linking empagliflozin to cardiovascular and renal protection
18. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes
19. Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function
20. Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes
21. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes
22. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study
23. DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives
24. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program
25. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes
26. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
27. Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
28. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
29. Usefulness of Subclinical Left Ventricular Midwall Dysfunction to Predict Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus
30. Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes
31. Triglyceride–high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus
32. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes
33. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
34. Endogenous hyperinsulinaemia in insulinoma patients is not associated with changes in beta-cell area and turnover in the tumor-adjacent pancreas
35. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
36. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: Role of kidney dysfunction
37. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients
38. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database
39. Protection of pancreatic beta-cells: Is it feasible?
40. The metabolic syndrome: Is it still alive?
41. Serum leptin level and the risk of nontraumatic fracture
42. Prevalence, ancillary clinical features and cardiovascular disease in the metabolic syndrome: the Bruneck study
43. Serum uric acid and related factors in 500 hospitalized subjects
44. Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism
45. Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements?
46. Influence of the menstrual cycle on glucose tolerance and insulin secretion
47. Decreased hepatic insulin extraction in subjects with mild glucose intolerance
48. Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.